PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Expenses
-$13.05M
TTM · Period ending: · USD
PHAS Operating Expenses
Latest reported-$13.05Mperiod ending
Latest reported-$13.05Mperiod ending
PHAS Operating Expenses ($9.50M → -$13.05M)
Annual operating expenses
High-resolution chart · PNG
PHAS operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 118,193 | |
| 85,176,000 | |
| 42,097,000 | |
| 20,312,000 | |
| 8,538,000 | |
| 9,501,000 |